CAS: 50892-23-4; 2-((4-Chloro-6-((2,3-Dimethylphenyl)Amino)Pyrimidin-2-yl)Thio)Acetic Acid

该化合物是非类类类非类固醇抗炎药物(NSAIDs)的化合物,其特点是能够抑制酶环氧基酶,该酶在合成蛋白兰地方面起着关键作用,从而减少炎和疼痛.Pirinixic酸的分子结构特征是盒状酸功能组,有助于其酸性能.它通常以钠盐的形式施用,以提高溶解性和生物利用率.对碘酸进行了研究,以了解其在各种炎情下的潜在治疗作用,尽管其临床用途可能因区域和管制批准状况而有所不同.此外,与许多非典新基物质一样,它可能与副作用有关,如胃肠不适或心血管风险,因此有必要对其应用进行仔细考虑.总体而言,Pirenixica酸体现了典型的NSID的特点,重点是反氟化和亚热特性.

结构式图片

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号87-59-2 2,3-二甲基苯胺 | CAS号50892-12-1 ethyl 2-(4,6-di... | CAS号50892-49-4 AKOS BC-1524 | CAS号65089-17-0 匹立昔尔 | CAS号86627-11-4 2-[4-(2,3-dimet...

合成工艺路线路线简述

    📜3-(二甲基氨基)-2-(2-噻吩羰基)-丙烯腈置于sodium Hydroxide,N,N-二乙基苯胺,三氯氧磷体系中,用 乙醇 作为反应溶剂,化学反应 17.03H,反应生成 匹立尼酸
    参考文献:Novel Pyrimidine And 1,3,5-Triazine Hypolipemic Agents
    标题:Novel Pyrimidine And 1,3,5-Triazine Hypolipemic Agents
    摘要:New Compounds Were Synthesized By Changing The Substituents Of A Trisubstituted Pyrimidine,I.E.,[[4-Chloro-6-[(2,3-Dimethylphenyl)Amino]-2-Pyrimidinyl]Thio] Acetic Acid,A Potent Hypolipidemic Agent,Impaired,However,By A Marked Hepatomegaly-Inducing Effect. The Structural Variations Led To The Subsidence (14B,I.E.,4-Chloro-2-(Dimethylamino)-6-[(2,3-Dimethylphenyl)Amino]Pyrimidine) Or To The Reduction (18B,[[4-Chloro-6-[(2,3-Dimethylphenyl)Amino]-2-Pyrimidinyl]Amino] Acetic Acid) Of Said Untoward Effect But Still Maintained The Hypolipidemic Effect That,Although Markedly Decreased,Still Proves Significant For Serum Cholesterol And Triglycerides (18B) Or For Serum Triglycerides Only (14B).
    DOI:10.1021/jm00378A016

    海关参考信息

    专利信息


    专利号:WO-2009117985-A1
    优先权日:2008-06-12
    标题 :Pirinixic acid derivatives as prostglandin e2 synthesis inhibitors for treating inflammatory diseases
    发明人:WERZ OLIVER; KOEBERLE ANDREAS; SCHUBERT-ZSILAVECZ MANFRED; POPESCU LAURA; SYHA YVONNE
    权利人:MEDEON PHARMACEUTICALS GMBH; UNIV TUEBINGEN; WERZ OLIVER; KOEBERLE ANDREAS; SCHUBERT-ZSILAVECZ MANFRED; POPESCU LAURA; SYHA YVONNE
    摘要:The invention relates to pirinixic acid derivatives, especially a-substituted pirinixic acids and pirinixic acid esters, and the structural derivatives thereof with the following structural formula. The pirinixic acid derivatives inhibit the PGE2 synthesis, especially that of the mPGES-1. The invention also relates to the use of said pirinixic acid derivatives for producing a medicament for treating prostaglandin E2-mediated diseases, especially inflammatory diseases, painful and feverish conditions, cardiovascular events and cancerous diseases associated with an increased inducible microsomal prostaglandin E2 synthesis-1 (mPGES-1) activity or increased prostaglandin E2 synthesis.

    专利号:WO-2022136897-A1
    优先权日:2020-12-23
    标题 :Cosmetic composition comprising an aqueous or an hydroalcoholic extract of peony
    发明人:CHOISY PATRICK; GOURGUILLON LORÈNE; NIZARD CARINE; LEBLANC EMMANUELLE
    权利人:LVMH RECH
    摘要:The present invention relates to a cosmetic composition comprising aqueous or hydroalcoholic extract of Paeonia suffruticosa Yao Huang, and the use thereof for anti- aging, in particular to promote and/or improve the barrier function, densify the extracellular matrix and/or reduce its degradation, improve the elasticity and/or firmness of the skin, improve the radiance and/or homogeneity of the skin, improve the collagen synthesis in the skin.

    专利号:DE-102008015432-A1
    优先权日:2008-06-12
    标题 :Use of pirinixic acid derivatives to inhibit prostaglandin E2 synthesis

    专利号:CN-119818387-A
    优先权日:2025-01-07
    标题 :Application of a cyclic peptide and its synthesis method

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Merk D, Zettl M, Steinhilber D, Werz O, Schubert-Zsilavecz M. Pirinixic acids: flexible fatty acid mimetics with various biological activities. Future Med Chem. 2015 Aug;7(12):1597-616. doi: 10.4155/fmc.15.87. Epub 2015 Aug 27. doi: 10.3109/01902148.2015.1046200. doi: 10.1016/j.biocel.2015.06.014. Epub 2015 Jun 19. doi: 10.1002/mnfr.201400743. Epub 2015 May 26. doi: 10.1038/mt.2015.64. Epub 2015 Apr 21. doi: 10.1152/ajpendo.00433.2014. Epub 2015 Mar 17. doi: 10.1161/CIRCGENETICS.114.000918. Epub 2015 Mar 10. doi: 10.1016/j.lfs.2015.02.003. Epub 2015 Mar 4. doi: 10.1089/jir.2014.0209. Epub 2015 Mar 3.
    10: Haffar T, Bérubé-Simard FA, Bousette N. Cardiomyocyte lipotoxicity is mediated by Il-6 and causes down-regulation of PPARs. Biochem Biophys Res Commun. 2015 Mar 27;459(1):54-9. doi: 10.1016/j.bbrc.2015.02.062. Epub 2015 Feb 21. doi: 10.1016/j.abb.2015.02.010. Epub 2015 Feb 20.
    12: Kang HS, Kim MY, Kim SJ, Lee JH, Kim YD, Seo YK, Bae JH, Oh GT, Song DK, Ahn YH, Im SS. Regulation of IGFBP-2 expression during fasting. Biochem J. 2015 May 1;467(3):453-60. doi: 10.1042/BJ20141248.

    合成参考文献


    摘要:Journal of Medicinal Chemistry., 27(1621), 1984
    摘要:
    摘要:
    摘要:Lewis, R.J. Sr. (ed) Sax's Dangerous Properties of Industrial Materials. 11th Edition. Wiley-Interscience, Wiley & Sons, Inc. Hoboken, NJ. 2004., p. 907
    摘要:Full text: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC116535
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知